Healthcare: Citi and others are bullish on biotech, medtech and more

2023 wasn't a good year for the health-care sector, but some investors expect it to rebound this year — highlighting biotech and medical tech as areas to watch.

Related Keywords

Jared Holz ,Matt Orton ,Abbott Laboratories ,Alnylam Pharmaceuticals ,Global Wealth Investments ,Biomea Fusion ,Mizuho Securities Americas ,Trent Masters ,Intuitive Surgical ,Raymond James Investment Management ,Stock Markets ,Biotech And Pharmaceuticals ,Biotechnology ,Health Care Industry ,Citi Trends Inc ,Dexcom Inc ,Intuitive Surgical Inc ,Biogen Inc ,Health Sciences Acquisitions Corp ,Alnylam Pharmaceuticals Inc ,Biomea Fusion Inc ,Business News ,